Skip to content

Clinical trials

Neurodegenerative Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: Poland Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20173
20181
20191
20203
20211
20223
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated4
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
AstraZeneca2
Alkahest, Inc.1
Bial R&D Investments, S.A.1
Eli Lilly and Company1
Emalex Biosciences Inc.1
Genentech, Inc.1
Hoffmann-La Roche1
Inmune Bio, Inc.1
Jagiellonian University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases17
Brain Diseases14
Central Nervous System Diseases13
Nervous System Diseases12
Dementia9
Alzheimer Disease8
Mental Disorders8
Movement Disorders7
Neurocognitive Disorders7
Parkinson Disease7

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.